OXY:NYSEOccidental Petroleum Corporation Analysis
Data as of 2026-03-10 - not real-time
$53.08
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock is trading above its 20‑day and 50‑day moving averages, with a bullish MACD crossover and an RSI that, while elevated, remains below the extreme overbought zone. Volume is on an upward trend, supporting the current price momentum.
Fundamental backdrop: Revenue has surged, margins are robust and operating cash flow comfortably exceeds free cash flow, yet leverage is high and the price‑to‑earnings multiple sits well above the sector average. Recent news of a dividend increase and the planned divestiture of the OxyChem segment adds upside to the narrative, while the DCF‑derived fair value is only marginally above the market price, suggesting a fairly‑priced entry point.
Fundamental backdrop: Revenue has surged, margins are robust and operating cash flow comfortably exceeds free cash flow, yet leverage is high and the price‑to‑earnings multiple sits well above the sector average. Recent news of a dividend increase and the planned divestiture of the OxyChem segment adds upside to the narrative, while the DCF‑derived fair value is only marginally above the market price, suggesting a fairly‑priced entry point.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish technical indicators but price still below short‑term resistance
- Elevated valuation multiples relative to peers
- Increasing volume confirming short‑term demand
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue growth and solid operating cash flow
- Dividend hike and improving payout sustainability
- Strategic refocus on core oil & gas assets after OxyChem sale
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Cyclical exposure to oil price volatility
- High debt load that could constrain future cash distribution
- Long‑term energy transition risk balanced by midstream diversification
Key Metrics & Analysis
Financial Health
Revenue Growth148.90%
Profit Margin10.77%
P/E Ratio39.3
ROE5.93%
ROA2.74%
Debt/Equity63.80
P/B Ratio1.9
Op. Cash Flow$10.5B
Free Cash Flow$2.1B
Industry P/E20.4
Technical Analysis
TrendBullish
RSI61.8
Support$44.86
Resistance$56.34
MA 20$50.92
MA 50$46.42
MA 200$44.20
MACDBullish
VolumeIncreasing
Fear & Greed Index77.55
Valuation
Fair Value$57.48
Target Price$52.52
Upside/Downside-1.06%
GradeFair
TypeBlend
Dividend Yield1.89%
Risk Assessment
Beta0.96
Volatility41.09%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.